Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 1
2(50.0%)
4Total
N/A(2)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06283173Not ApplicableCompleted

HRIPT for Collagen Dressing

Role: lead

NCT01368146Phase 1Completed

Human Repeat Insult Patch Test of Wound Dressings

Role: lead

NCT06271993Not ApplicableCompleted

SPT for Sensitization of Collagen Dressing

Role: lead

NCT01368120Phase 1Completed

Antimicrobial Activity of IV Clear™ Dressing - Prevention of Antimicrobial Regrowth

Role: lead

All 4 trials loaded